Quest Diagnostics Incorporated
241.89USD
-1.3900 (-0.57%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on DGX.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.68▲ | $2.66 | 2 | 0 |
| Next quarter | $2.71▼ | $2.73 | 5 | 1 |
| Current year | $11.29▲ | $11.07 | 2 | 1 |
| Next year | $11.98▲ | $11.94 | 2 | 3 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-09-30 | $2.87 | $3 | +0.13 (+4.4%) |
| 2026-06-30 | $2.82 | $3.12 | +0.30 (+10.5%) |
| 2026-03-31 | $2.37 | $2.5 | +0.13 (+5.6%) |
| 2025-12-31 | $2.36 | $2.42 | +0.06 (+2.6%) |
258 ratings from 32 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Overweight | $250 $260 | Oct 7, 2026 |
| Truist Securities | Maintained | Hold | $250 $260 | Sep 21, 2026 |
| UBS | Maintained | Neutral | $232 $245 | Sep 8, 2026 |
| JP Morgan | Maintained | Neutral | $220 $250 | Jul 28, 2026 |
| UBS | Maintained | Neutral | $220 $232 | Jul 25, 2026 |
| Mizuho | Maintained | Outperform | $235 $260 | Jul 24, 2026 |
| Truist Securities | Maintained | Hold | $225 $250 | Jul 24, 2026 |
| Barclays | Maintained | Overweight | $230 $250 | Jul 24, 2026 |
| Baird | Maintained | Neutral | $236 $255 | Jul 24, 2026 |
| Baird | Maintained | Neutral | $232 $236 | Jul 13, 2026 |
| UBS | Maintained | Neutral | $210 $220 | Apr 22, 2026 |
| Baird | Maintained | Neutral | $224 $229 | Apr 22, 2026 |
| Barclays | Maintained | Overweight | $225 $230 | Apr 22, 2026 |
| Truist Securities | Maintained | Hold | $220 $225 | Apr 22, 2026 |
| Evercore ISI Group | Maintained | In-Line | $220 $210 | Apr 8, 2026 |
| Mizuho | Maintained | Outperform | $210 $235 | Feb 12, 2026 |
| Truist Securities | Maintained | Hold | $205 $220 | Feb 11, 2026 |
| UBS | Maintained | Neutral | $190 $210 | Feb 11, 2026 |
| Evercore ISI Group | Maintained | In-Line | $190 $220 | Feb 11, 2026 |
| Barclays | Maintained | Overweight | $210 $225 | Feb 11, 2026 |
| Jefferies | Maintained | Buy | $215 $220 | Feb 11, 2026 |
| Citigroup | Maintained | Neutral | $190 $215 | Feb 10, 2026 |
| Piper Sandler | Maintained | Neutral | $190 $200 | Oct 27, 2025 |
| Barclays | Maintained | Equal-Weight | $190 $195 | Oct 22, 2025 |
| Truist Securities | Maintained | Hold | $195 $205 | Oct 22, 2025 |
166 filings from 25 insiders · 27 buy / 4 sell over 6m
Officers and directors of DGX, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| CARTER ROBERT BDirector | Other | 10 | $235.93 | $2k | Oct 21, 2026 |
| SAMAD SAMOfficer, Executive Vice President & CFO | Grant | 90 | $235.94 | $21k | Oct 21, 2026 |
| Gregg Vicky BDirector | Grant | 63 | $235.94 | $15k | Oct 21, 2026 |
| KUPPUSAMY KARTHIKOfficer, SVP, Clinical Solutions | Other | 33 | $235.94 | $8k | Oct 21, 2026 |
| Lassiter Wright IIIDirector | Other | 6 | $235.96 | $1k | Oct 21, 2026 |
| Plewman PatrickOfficer, SVP for Diagnostic Services | Other | 41 | $235.94 | $10k | Oct 21, 2026 |
| MAIN TIMOTHY LDirector | Other | 18 | $235.94 | $4k | Oct 21, 2026 |
| DELANEY MARK EOfficer, SVP & Chief Commercial Officer | Other | 25 | $235.94 | $6k | Oct 21, 2026 |
| WENTWORTH TIMOTHY CDirector | GrantPhantom Stock Units | 135 | — | — | Oct 1, 2026 |
| Davis J. E.Director; Officer, CEO and President | Sell | 10.0k | $242.72 | $2.43M | Sep 1, 2026 |
| PREVOZNIK MICHAEL EOfficer, SVP & General Counsel | ExerciseNon-Qualifed Stock Option (right to buy) | 22.7k | $112.17 | $2.54M | Aug 28, 2026 |
| PREVOZNIK MICHAEL EOfficer, SVP & General Counsel | Gift | 1.0k | — | — | Aug 28, 2026 |
| PREVOZNIK MICHAEL EOfficer, SVP & General Counsel | Sell | 430 | $244.51 | $105k | Aug 28, 2026 |
| PREVOZNIK MICHAEL EOfficer, SVP & General Counsel | Sell | 6.2k | $243.63 | $1.52M | Aug 28, 2026 |
| PREVOZNIK MICHAEL EOfficer, SVP & General Counsel | Sell | 16.0k | $242.88 | $3.89M | Aug 28, 2026 |
| PREVOZNIK MICHAEL EOfficer, SVP & General Counsel | Exercise | 22.7k | $112.17 | $2.54M | Aug 28, 2026 |
| DELANEY MARK EOfficer | Sell | 1.6k | $235.18 | $376k | Jul 28, 2026 |
| MAIN TIMOTHY LDirector | Buy | 21 | $206.81 | $4k | Jul 22, 2026 |
| CARTER ROBERT BDirector | Buy | 11 | $206.80 | $2k | Jul 22, 2026 |
| PLEWMAN PATRICKOfficer | Buy | 46 | $206.81 | $10k | Jul 22, 2026 |
No analyst notes on DGX yet.
Members whose judged calls on DGX have played out most reliably.
No settled calls on DGX yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
15 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 7 | 8 | 0 | 0 | Buy2.35 |
| 1 mo ago | 2 | 7 | 7 | 0 | 1 | Buy2.47 |
| 2 mo ago | 2 | 7 | 7 | 0 | 1 | Buy2.47 |
| 3 mo ago | 2 | 7 | 7 | 0 | 1 | Buy2.47 |